28
Participants
Start Date
April 28, 2016
Primary Completion Date
March 29, 2019
Study Completion Date
March 29, 2019
PF-06671008
Dose Escalation Phase - Part 1
PF-06671008
Dose Expansion Phase - Part 2
Memorial Sloan Kettering Cancer Center- Clinical Trials Office, New York
Memorial Sloan Kettering Cancer Center Rockefeller Outpatient Pavillion, New York
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center - Westchester, Harrison
University Hospitals Cleveland Medical Center, Cleveland
The University of Texas - M.D. Anderson Cancer Center, Houston
The University of Texas MD Anderson Cancer Center, Houston
Huntsman Cancer Hospital, Salt Lake City
Huntsman Cancer Institute, Salt Lake City
Lead Sponsor
Pfizer
INDUSTRY